Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Revolution Medicines (RVMD) Other Non-Current Assets: 2019-2025

Historic Other Non-Current Assets for Revolution Medicines (RVMD) over the last 7 years, with Sep 2025 value amounting to $16.9 million.

  • Revolution Medicines' Other Non-Current Assets rose 64.00% to $16.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.9 million, marking a year-over-year increase of 64.00%. This contributed to the annual value of $12.1 million for FY2024, which is 72.47% up from last year.
  • According to the latest figures from Q3 2025, Revolution Medicines' Other Non-Current Assets is $16.9 million, which was down 46.37% from $31.4 million recorded in Q2 2025.
  • Over the past 5 years, Revolution Medicines' Other Non-Current Assets peaked at $31.4 million during Q2 2025, and registered a low of $1.1 million during Q1 2021.
  • For the 3-year period, Revolution Medicines' Other Non-Current Assets averaged around $10.9 million, with its median value being $10.3 million (2024).
  • Per our database at Business Quant, Revolution Medicines' Other Non-Current Assets soared by 553.54% in 2023 and then fell by 9.49% in 2024.
  • Revolution Medicines' Other Non-Current Assets (Quarterly) stood at $1.7 million in 2021, then skyrocketed by 64.48% to $2.9 million in 2022, then skyrocketed by 146.13% to $7.0 million in 2023, then spiked by 72.47% to $12.1 million in 2024, then spiked by 64.00% to $16.9 million in 2025.
  • Its Other Non-Current Assets stands at $16.9 million for Q3 2025, versus $31.4 million for Q2 2025 and $13.1 million for Q1 2025.